S 3697119th CongressIn Committee

SAVE Moms and Babies Act of 2026

Standard Summary
Balanced plain-English summary

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit FDA approval of new abortion drugs and to bar investigational use exemptions for abortion drugs or investigations that knowingly destroy an unborn child. For previously approved abortion drugs, it imposes labeling limits, in-person dispensing requirements, risk evaluation and mitigation strategy obligations, adverse event reporting, and state-law reporting requirements, while rescinding certain ongoing investigational exemptions after three years.

Key Points

  • 1Prohibits FDA approval of new abortion drugs and related investigational use exemptions.
  • 2Imposes restrictions on previously approved abortion drugs, including labeling limits after 70 days gestation and in-person dispensing.
  • 3Requires a risk evaluation and mitigation strategy with prescriber certification, patient documentation, and adverse event reporting.
  • 4Rescinds certain existing investigational use exemptions three years after enactment.

Impact Areas

patients seeking abortion carehealthcare practitionerspharmaciesdrug manufacturersFood and Drug Administrationstate health regulators
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026